Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease

Detalles Bibliográficos
Autores principales: Kaloyannidis, Panayotis, Shaibani, Eshrak Al, Apostolidis, Ioannis, Kanfar, Solaf, Anezi, Khalid Al, Hashmi, Hani Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760676/
https://www.ncbi.nlm.nih.gov/pubmed/30337698
http://dx.doi.org/10.1038/s41409-018-0362-7
_version_ 1783453907599491072
author Kaloyannidis, Panayotis
Shaibani, Eshrak Al
Apostolidis, Ioannis
Kanfar, Solaf
Anezi, Khalid Al
Hashmi, Hani Al
author_facet Kaloyannidis, Panayotis
Shaibani, Eshrak Al
Apostolidis, Ioannis
Kanfar, Solaf
Anezi, Khalid Al
Hashmi, Hani Al
author_sort Kaloyannidis, Panayotis
collection PubMed
description
format Online
Article
Text
id pubmed-6760676
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67606762019-12-23 Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease Kaloyannidis, Panayotis Shaibani, Eshrak Al Apostolidis, Ioannis Kanfar, Solaf Anezi, Khalid Al Hashmi, Hani Al Bone Marrow Transplant Correspondence Nature Publishing Group UK 2018-10-18 2019 /pmc/articles/PMC6760676/ /pubmed/30337698 http://dx.doi.org/10.1038/s41409-018-0362-7 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Kaloyannidis, Panayotis
Shaibani, Eshrak Al
Apostolidis, Ioannis
Kanfar, Solaf
Anezi, Khalid Al
Hashmi, Hani Al
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
title Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
title_full Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
title_fullStr Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
title_full_unstemmed Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
title_short Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
title_sort combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760676/
https://www.ncbi.nlm.nih.gov/pubmed/30337698
http://dx.doi.org/10.1038/s41409-018-0362-7
work_keys_str_mv AT kaloyannidispanayotis combinationofbortezomibplusruxolitinibinsteroidrefractorychronicgraftversushostdisease
AT shaibanieshrakal combinationofbortezomibplusruxolitinibinsteroidrefractorychronicgraftversushostdisease
AT apostolidisioannis combinationofbortezomibplusruxolitinibinsteroidrefractorychronicgraftversushostdisease
AT kanfarsolaf combinationofbortezomibplusruxolitinibinsteroidrefractorychronicgraftversushostdisease
AT anezikhalidal combinationofbortezomibplusruxolitinibinsteroidrefractorychronicgraftversushostdisease
AT hashmihanial combinationofbortezomibplusruxolitinibinsteroidrefractorychronicgraftversushostdisease

Ejemplares similares